Description
A 10 mM (5 mg in 1.13 ml) solution of LDN193189 (Cat. No. 1995-5) in anhydrous DMSO.
EZSolution™ LDN193189 is a 10 mM (5 mg in 1.13 ml) solution of LDN193189 (Cat. No. 1995-5) in anhydrous DMSO.
2092 | LDN193189 HCl DataSheet
Alternate Name/Synonyms: 4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;hydrochloride; DM-3189 (hydrochloride). Please remove 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine, hydrochloride; DM-3189
Appearance: Liquid
Formulation: A 10 mM solution in DMSO
CAS Number: 1062368-24-4 (free base)
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₅H₂₂N₆.HCl
Molecular Weight: 442.94
Cell-Permeable?: Yes
Purity: ≥97% by HPLC
Solubilities: DMSO (10 mM)
Handling: Protect from light and moisture
Country of Origin: USA
Tag Line: A potent BMP type I receptor inhibitor
MDL Number: MFCD17392570
PubChem CID: 54613581
SMILES: C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3.Cl InChi:InChI=1S/C25H22N6.ClH/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30;/h1-10,15-17,26H,11-14H2;1H
InChi: InChI=1S/C25H22N6.ClH/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30;/h1-10,15-17,26H,11-14H2;1H
InChi Key: PCCDKTWDGDFRME-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
24months |